Cancer patients respond to flu vaccine
A new study reveals that cancer patients treated with the drugs sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared.
Doctors are urging patients to be vaccinated as another flu season looms, rolling up their sleeves to get the shots themselves and encouraging others in health care to do the same.